These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 6481115

  • 1. The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy.
    McClain CJ, Potter TJ, Kromhout JP, Zieve L.
    J Clin Gastroenterol; 1984 Aug; 6(4):325-9. PubMed ID: 6481115
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Oral bacteriotherapy with Bifidobacterium bifidum and Lactobacillus acidophilus in cirrhotic patients].
    Colle R, Ceschia T.
    Clin Ter; 1989 Dec 31; 131(6):397-402. PubMed ID: 2534368
    [Abstract] [Full Text] [Related]

  • 8. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    Eur J Gastroenterol Hepatol; 2008 Jun 31; 20(6):506-11. PubMed ID: 18467909
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A, Bianco S, Bergonzi P, Cagossi M, Civello IM, Borzone A, Nanni G, Pigliucci GM.
    Chir Patol Sper; 1975 Apr 31; 23(2):77-95. PubMed ID: 1140038
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC, Sharma P, Agrawal A, Sarin SK.
    Gastroenterology; 2009 Sep 31; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lactulose for hepatic encephalopathy.
    Med Lett Drugs Ther; 1976 Jan 02; 18(1):3-4. PubMed ID: 1105127
    [No Abstract] [Full Text] [Related]

  • 17. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.
    Weber FL, Fresard KM, Lally BR.
    Gastroenterology; 1982 Feb 02; 82(2):213-7. PubMed ID: 7054022
    [Abstract] [Full Text] [Related]

  • 18. [Lactulose in the therapy of porto-systemic encephalopathy].
    Almici C, Inzoli MR, Poloni AE, Zambruni A.
    Minerva Med; 1973 Dec 05; 64(87):4596-603. PubMed ID: 4774227
    [No Abstract] [Full Text] [Related]

  • 19. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L, Frexinos J, Louis A, Ribet A.
    Arch Fr Mal App Dig; 1973 Jun 05; 62(4):293-302. PubMed ID: 4594755
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.